In vitro Assessment of Environmental Compound-Induced Cardiotoxicity Potential Using Human Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes

被引：0
|
作者：
Sirenko, O. [1 ]
Kristen, R. R. [2 ]
Behl, M. [2 ,3 ]
Parham, F. [2 ]
Anson, B. [4 ]
Cromwell, E. F. [1 ]
Tice, R. R. [2 ]
机构：
[1] Mol Devices LLC, Sunnyvale, CA USA
[2] NIEHS, Div Natl Toxicol Program, NIH, Res Triangle Pk, NC USA
[3] Kelly Govt Solut, Res Triangle Pk, NC USA
[4] Cellular Dynam Int, Madison, WI USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1086
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Yanagida, Shota
    Satsuka, Ayano
    Hayashi, Sayo
    Ono, Atsushi
    Kanda, Yasunari
    TOXICOLOGICAL SCIENCES, 2021, 183 (01) : 227 - 239
  • [32] In vitro disease model development using human induced pluripotent stem cell-derived cardiomyocytes
    Huang, Minxue
    Raghupathy, Narayanan
    Chen, Shen-Jue
    Levesque, Paul
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [33] Preventing Anthracycline-Induced Cardiotoxicity Using Functional Genomics and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Lo Sardo, Valentina
    Kamp, Timothy J.
    CIRCULATION, 2022, 145 (04) : 295 - 298
  • [34] Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Gong, Yiqi
    Yang, Li
    Tang, Jun
    Zheng, Jijian
    Witman, Nevin
    Jakob, Philipp
    Tan, Yao
    Liu, Minglu
    Chen, Ying
    Wang, Huijing
    Fu, Wei
    Wang, Wei
    CARDIOVASCULAR TOXICOLOGY, 2022, 22 (02) : 141 - 151
  • [35] Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Yiqi Gong
    Li Yang
    Jun Tang
    Jijian Zheng
    Nevin Witman
    Philipp Jakob
    Yao Tan
    Minglu Liu
    Ying Chen
    Huijing Wang
    Wei Fu
    Wei Wang
    Cardiovascular Toxicology, 2022, 22 : 141 - 151
  • [36] Cardiotoxicity of chemotherapeutic agents assessed in human embryonic or induced pluripotent stem cell-derived cardiomyocytes
    Mioulane, M.
    Foldes, G.
    Harding, S. E.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S47 - S47
  • [37] Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Narkar, Akshay
    Willard, James M.
    Blinova, Ksenia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [38] Investigation on arrhythmogenic potential of phenanthrene using human induced pluripotent stem cell-derived cardiomyocytes
    Kim, Min Woo
    Lee, Seul-Gi
    Kim, Jin
    Jeong, Kyu Sik
    Lee, Yun Hyeong
    Lee, Suemin
    Park, Jeong Hwan
    Jeong, Youngin
    Lee, Myeonghee
    Kim, Yoonseo
    Chung, Hyung Min
    Kim, C-Yoon
    MOLECULAR & CELLULAR TOXICOLOGY, 2024,
  • [39] Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Huang, Mo-Fan
    Pang, Lon Kai
    Chen, Yi-Hung
    Zhao, Ruiying
    Lee, Dung-Fang
    CELLS, 2021, 10 (11)
  • [40] Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products
    Simms, Liam
    Yu, Fan
    Palmer, Jessica
    Rudd, Kathryn
    Sticken, Edgar Trelles
    Wieczorek, Roman
    Chapman, Fiona
    Czekala, Lukasz
    Stevenson, Matthew
    O'Connell, Grant
    FRONTIERS IN TOXICOLOGY, 2022, 4
12345